Stacy E.F. Melanson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse Detection | 19 | 2025 | 301 | 5.280 |
Why?
|
| Immunoassay | 13 | 2024 | 742 | 3.000 |
Why?
|
| Tandem Mass Spectrometry | 13 | 2024 | 1194 | 2.350 |
Why?
|
| Chromatography, Liquid | 12 | 2024 | 991 | 2.350 |
Why?
|
| Urinalysis | 9 | 2025 | 369 | 2.250 |
Why?
|
| Phlebotomy | 6 | 2017 | 138 | 1.560 |
Why?
|
| Drug Monitoring | 7 | 2021 | 960 | 1.540 |
Why?
|
| Laboratories | 10 | 2021 | 463 | 1.430 |
Why?
|
| Clinical Laboratory Information Systems | 4 | 2017 | 108 | 1.390 |
Why?
|
| Fentanyl | 4 | 2024 | 451 | 1.220 |
Why?
|
| Analgesics, Opioid | 13 | 2024 | 3834 | 1.050 |
Why?
|
| Cannabis | 2 | 2023 | 446 | 1.030 |
Why?
|
| Chemistry, Clinical | 5 | 2024 | 64 | 1.000 |
Why?
|
| Buprenorphine | 4 | 2019 | 665 | 0.910 |
Why?
|
| Saliva | 2 | 2019 | 851 | 0.830 |
Why?
|
| Clinical Laboratory Techniques | 4 | 2024 | 747 | 0.790 |
Why?
|
| Efficiency, Organizational | 4 | 2017 | 694 | 0.770 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 4416 | 0.770 |
Why?
|
| Piracetam | 1 | 2021 | 88 | 0.740 |
Why?
|
| Cannabinoids | 1 | 2023 | 174 | 0.710 |
Why?
|
| Blood Specimen Collection | 4 | 2018 | 238 | 0.680 |
Why?
|
| Workflow | 7 | 2021 | 857 | 0.650 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 458 | 0.640 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2014 | 499 | 0.640 |
Why?
|
| Troponin I | 5 | 2015 | 656 | 0.600 |
Why?
|
| Medication Adherence | 4 | 2017 | 2190 | 0.590 |
Why?
|
| Hallucinogens | 1 | 2021 | 211 | 0.580 |
Why?
|
| Academic Medical Centers | 5 | 2018 | 2780 | 0.540 |
Why?
|
| Patient Compliance | 3 | 2019 | 2693 | 0.520 |
Why?
|
| Clonazepam | 1 | 2016 | 135 | 0.500 |
Why?
|
| Myoglobin | 2 | 2006 | 157 | 0.490 |
Why?
|
| Pain | 5 | 2014 | 5076 | 0.470 |
Why?
|
| Coma | 1 | 2018 | 485 | 0.460 |
Why?
|
| Hospital Information Systems | 1 | 2017 | 395 | 0.460 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1697 | 0.450 |
Why?
|
| Analgesics | 4 | 2021 | 1057 | 0.440 |
Why?
|
| Emergency Service, Hospital | 9 | 2024 | 7872 | 0.440 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2006 | 1736 | 0.430 |
Why?
|
| Vancomycin | 2 | 2013 | 504 | 0.430 |
Why?
|
| Electronic Health Records | 5 | 2018 | 4864 | 0.430 |
Why?
|
| Laboratories, Hospital | 4 | 2017 | 192 | 0.410 |
Why?
|
| Point-of-Care Systems | 5 | 2022 | 1216 | 0.410 |
Why?
|
| Glucuronidase | 1 | 2014 | 205 | 0.410 |
Why?
|
| Limit of Detection | 3 | 2024 | 272 | 0.400 |
Why?
|
| Benzodiazepines | 2 | 2018 | 1135 | 0.390 |
Why?
|
| Pharmaceutical Preparations | 1 | 2019 | 1084 | 0.370 |
Why?
|
| Creatine Kinase, MB Form | 2 | 2014 | 202 | 0.370 |
Why?
|
| Sensitivity and Specificity | 12 | 2023 | 14644 | 0.360 |
Why?
|
| False Positive Reactions | 5 | 2018 | 957 | 0.360 |
Why?
|
| Humans | 89 | 2025 | 765823 | 0.350 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2010 | 110 | 0.340 |
Why?
|
| Legislation, Drug | 2 | 2023 | 216 | 0.340 |
Why?
|
| Narcotics | 1 | 2012 | 333 | 0.340 |
Why?
|
| Patient Identification Systems | 1 | 2010 | 75 | 0.340 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 246 | 0.330 |
Why?
|
| Peptide Fragments | 3 | 2006 | 5127 | 0.330 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 2176 | 0.300 |
Why?
|
| Troponin T | 3 | 2011 | 785 | 0.290 |
Why?
|
| Pain Measurement | 2 | 2018 | 3559 | 0.290 |
Why?
|
| Cost Savings | 1 | 2013 | 903 | 0.290 |
Why?
|
| Autoanalysis | 1 | 2007 | 70 | 0.290 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2009 | 391 | 0.280 |
Why?
|
| Medical Errors | 2 | 2018 | 1257 | 0.280 |
Why?
|
| Enzyme Multiplied Immunoassay Technique | 1 | 2006 | 7 | 0.280 |
Why?
|
| Promethazine | 1 | 2006 | 29 | 0.280 |
Why?
|
| Benchmarking | 1 | 2013 | 1054 | 0.270 |
Why?
|
| Fish Oils | 2 | 2005 | 483 | 0.270 |
Why?
|
| Epilepsy | 1 | 2021 | 3317 | 0.260 |
Why?
|
| Boston | 6 | 2024 | 9336 | 0.260 |
Why?
|
| Blood Gas Analysis | 1 | 2007 | 382 | 0.250 |
Why?
|
| Amphetamine | 1 | 2006 | 222 | 0.250 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 3474 | 0.240 |
Why?
|
| Troponin | 2 | 2014 | 533 | 0.240 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 427 | 0.240 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2224 | 0.240 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2006 | 239 | 0.230 |
Why?
|
| Vaccines | 2 | 2024 | 841 | 0.230 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2014 | 788 | 0.230 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2006 | 427 | 0.230 |
Why?
|
| Clinical Chemistry Tests | 1 | 2004 | 59 | 0.230 |
Why?
|
| Donor Selection | 1 | 2006 | 242 | 0.230 |
Why?
|
| Blood Donors | 1 | 2006 | 342 | 0.230 |
Why?
|
| Health Planning Guidelines | 1 | 2005 | 151 | 0.230 |
Why?
|
| Drug Prescriptions | 3 | 2011 | 1662 | 0.220 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2005 | 120 | 0.220 |
Why?
|
| Peroxidase | 1 | 2006 | 604 | 0.220 |
Why?
|
| Ambulatory Care | 1 | 2014 | 2776 | 0.210 |
Why?
|
| Colorado | 1 | 2023 | 167 | 0.210 |
Why?
|
| Medical History Taking | 1 | 2006 | 778 | 0.200 |
Why?
|
| Running | 1 | 2006 | 489 | 0.190 |
Why?
|
| Education, Medical | 1 | 2013 | 1746 | 0.190 |
Why?
|
| Reproducibility of Results | 7 | 2024 | 20131 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 2307 | 0.180 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 102 | 0.180 |
Why?
|
| Outpatients | 3 | 2021 | 1591 | 0.170 |
Why?
|
| Creatinine | 3 | 2022 | 1916 | 0.170 |
Why?
|
| Pandemics | 4 | 2024 | 8698 | 0.170 |
Why?
|
| Acute Coronary Syndrome | 2 | 2014 | 2184 | 0.170 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2019 | 20 | 0.170 |
Why?
|
| Blood Transfusion | 1 | 2006 | 1295 | 0.160 |
Why?
|
| Antibodies, Viral | 4 | 2024 | 3210 | 0.160 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2020 | 1527 | 0.160 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 992 | 0.160 |
Why?
|
| Bicycling | 1 | 2020 | 176 | 0.160 |
Why?
|
| Immunochemistry | 1 | 2018 | 116 | 0.150 |
Why?
|
| Analgesia, Obstetrical | 1 | 2020 | 169 | 0.150 |
Why?
|
| Dyspnea | 1 | 2006 | 1351 | 0.150 |
Why?
|
| Ethanol | 1 | 2024 | 1324 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 1167 | 0.150 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 1527 | 0.150 |
Why?
|
| Mercury | 2 | 2005 | 291 | 0.140 |
Why?
|
| Chest Pain | 1 | 2004 | 1101 | 0.140 |
Why?
|
| Myocardial Infarction | 3 | 2015 | 11506 | 0.140 |
Why?
|
| Analgesia, Epidural | 1 | 2020 | 332 | 0.140 |
Why?
|
| Naloxone | 1 | 2019 | 373 | 0.130 |
Why?
|
| Attitude to Computers | 1 | 2017 | 196 | 0.130 |
Why?
|
| Body Fluids | 1 | 2018 | 321 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2010 | 6607 | 0.120 |
Why?
|
| Quality Control | 1 | 2018 | 835 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2005 | 1396 | 0.120 |
Why?
|
| Automobile Driving | 1 | 2020 | 441 | 0.120 |
Why?
|
| Morphine | 2 | 2014 | 660 | 0.120 |
Why?
|
| Pathology, Clinical | 1 | 2018 | 374 | 0.120 |
Why?
|
| Accidents, Traffic | 1 | 2020 | 818 | 0.120 |
Why?
|
| Myocardium | 1 | 2007 | 4763 | 0.120 |
Why?
|
| Immunoglobulin G | 2 | 2024 | 4526 | 0.120 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 590 | 0.110 |
Why?
|
| Kidney Function Tests | 2 | 2008 | 684 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2022 | 6422 | 0.110 |
Why?
|
| United States | 6 | 2025 | 72896 | 0.110 |
Why?
|
| Female | 19 | 2024 | 396050 | 0.110 |
Why?
|
| Specimen Handling | 3 | 2019 | 703 | 0.110 |
Why?
|
| Middle Aged | 16 | 2024 | 223016 | 0.110 |
Why?
|
| Refrigeration | 1 | 2013 | 27 | 0.110 |
Why?
|
| Porphyrias | 1 | 2003 | 56 | 0.110 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2013 | 38 | 0.110 |
Why?
|
| Morphine Derivatives | 1 | 2013 | 43 | 0.110 |
Why?
|
| Urate Oxidase | 1 | 2013 | 33 | 0.110 |
Why?
|
| Calibration | 1 | 2016 | 814 | 0.110 |
Why?
|
| Documentation | 1 | 2019 | 915 | 0.100 |
Why?
|
| Walking | 1 | 2020 | 1198 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2007 | 5923 | 0.100 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 2599 | 0.100 |
Why?
|
| Forensic Toxicology | 1 | 2012 | 5 | 0.100 |
Why?
|
| Urine | 1 | 2014 | 363 | 0.100 |
Why?
|
| Tramadol | 1 | 2013 | 63 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5753 | 0.100 |
Why?
|
| Oligopeptides | 3 | 2004 | 1193 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2006 | 5089 | 0.100 |
Why?
|
| Time | 1 | 2013 | 549 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2005 | 3425 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1919 | 0.100 |
Why?
|
| Adult | 12 | 2024 | 223055 | 0.090 |
Why?
|
| Health Personnel | 1 | 2025 | 3386 | 0.090 |
Why?
|
| Time Factors | 6 | 2017 | 40109 | 0.090 |
Why?
|
| Physical Exertion | 2 | 2006 | 666 | 0.090 |
Why?
|
| Male | 20 | 2024 | 363740 | 0.090 |
Why?
|
| Glucose | 1 | 2022 | 4332 | 0.090 |
Why?
|
| Myeloablative Agonists | 1 | 2010 | 215 | 0.080 |
Why?
|
| Creatine Kinase | 3 | 2014 | 682 | 0.080 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2010 | 69 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 2418 | 0.080 |
Why?
|
| Substance P | 2 | 2000 | 331 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1943 | 0.080 |
Why?
|
| Oxycodone | 1 | 2010 | 144 | 0.080 |
Why?
|
| Cocaine | 1 | 2013 | 945 | 0.080 |
Why?
|
| Automation | 1 | 2011 | 585 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2024 | 81505 | 0.070 |
Why?
|
| Reference Values | 3 | 2014 | 4911 | 0.070 |
Why?
|
| Uric Acid | 1 | 2013 | 808 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 2 | 2022 | 2233 | 0.070 |
Why?
|
| Ultrasonography | 2 | 1999 | 5995 | 0.070 |
Why?
|
| Acute Disease | 2 | 2007 | 7237 | 0.060 |
Why?
|
| Teratogens | 1 | 2006 | 120 | 0.060 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 341 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2350 | 0.060 |
Why?
|
| Serum | 1 | 2006 | 206 | 0.060 |
Why?
|
| Reference Standards | 2 | 2022 | 1013 | 0.060 |
Why?
|
| Aged | 7 | 2024 | 171178 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2020 | 26337 | 0.060 |
Why?
|
| Cross Reactions | 1 | 2006 | 824 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5368 | 0.060 |
Why?
|
| Receptors, Tachykinin | 1 | 2004 | 25 | 0.060 |
Why?
|
| Data Collection | 2 | 2011 | 3317 | 0.060 |
Why?
|
| Pesticide Residues | 1 | 2005 | 95 | 0.060 |
Why?
|
| Nurses | 1 | 2013 | 2505 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2004 | 158 | 0.050 |
Why?
|
| Inpatients | 2 | 2014 | 2564 | 0.050 |
Why?
|
| Anti-Anxiety Agents | 1 | 2006 | 402 | 0.050 |
Why?
|
| Fiber Optic Technology | 1 | 1995 | 284 | 0.050 |
Why?
|
| Cytokines | 1 | 2019 | 7425 | 0.050 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 1635 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2004 | 144 | 0.050 |
Why?
|
| Societies | 1 | 2024 | 106 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3925 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2005 | 528 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1393 | 0.050 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2005 | 234 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2004 | 527 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 2 | 2023 | 2010 | 0.050 |
Why?
|
| Albumins | 1 | 2005 | 577 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2008 | 15398 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2018 | 5944 | 0.050 |
Why?
|
| Probability | 1 | 2006 | 2475 | 0.050 |
Why?
|
| Hospitals | 2 | 2022 | 3887 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2023 | 54798 | 0.050 |
Why?
|
| ROC Curve | 2 | 2006 | 3617 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2024 | 427 | 0.050 |
Why?
|
| Capnography | 1 | 2001 | 90 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 263 | 0.040 |
Why?
|
| Apgar Score | 1 | 2020 | 125 | 0.040 |
Why?
|
| American Heart Association | 1 | 2005 | 1046 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2010 | 10087 | 0.040 |
Why?
|
| Alleles | 1 | 2010 | 6893 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2004 | 1688 | 0.040 |
Why?
|
| Commerce | 1 | 2005 | 611 | 0.040 |
Why?
|
| Canada | 1 | 2025 | 2119 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 621 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2235 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2014 | 4303 | 0.040 |
Why?
|
| Injections, Spinal | 2 | 2013 | 308 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 1927 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 475 | 0.040 |
Why?
|
| Workload | 1 | 2004 | 850 | 0.040 |
Why?
|
| Indoles | 2 | 2004 | 1832 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2005 | 1536 | 0.040 |
Why?
|
| Polymers | 1 | 1995 | 1623 | 0.040 |
Why?
|
| Vitamin D | 1 | 2012 | 3272 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 453 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39226 | 0.040 |
Why?
|
| Blood Banks | 1 | 2018 | 108 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2687 | 0.030 |
Why?
|
| Maternal Age | 1 | 2020 | 804 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1922 | 0.030 |
Why?
|
| Emergency Medical Technicians | 1 | 1997 | 119 | 0.030 |
Why?
|
| Genotype | 1 | 2010 | 13023 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 12966 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3736 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2021 | 1167 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2020 | 950 | 0.030 |
Why?
|
| Risk | 1 | 2006 | 9600 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2006 | 2771 | 0.030 |
Why?
|
| Logistic Models | 2 | 2006 | 13266 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 2902 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2008 | 5594 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2009 | 9355 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2007 | 3799 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7476 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2019 | 1183 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2001 | 995 | 0.030 |
Why?
|
| History, 18th Century | 1 | 2003 | 206 | 0.030 |
Why?
|
| Temperature | 1 | 2019 | 2226 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2019 | 1896 | 0.020 |
Why?
|
| HIV | 1 | 1999 | 1585 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 14062 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7416 | 0.020 |
Why?
|
| Self Report | 1 | 2023 | 3768 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2013 | 434 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2001 | 1515 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 59506 | 0.020 |
Why?
|
| Clinical Competence | 2 | 2025 | 4860 | 0.020 |
Why?
|
| Drug Tolerance | 2 | 2004 | 365 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2003 | 711 | 0.020 |
Why?
|
| RNA, Viral | 1 | 1999 | 2863 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3425 | 0.020 |
Why?
|
| Seafood | 1 | 2003 | 395 | 0.020 |
Why?
|
| Fishes | 1 | 2003 | 607 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3160 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 4056 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9241 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13446 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 1999 | 1221 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1276 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 1667 | 0.020 |
Why?
|
| Palliative Care | 1 | 2024 | 3640 | 0.020 |
Why?
|
| Echocardiography | 1 | 2001 | 5042 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Pennsylvania | 2 | 1999 | 616 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2004 | 8105 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1997 | 2129 | 0.020 |
Why?
|
| Artifacts | 1 | 2014 | 1893 | 0.020 |
Why?
|
| Internationality | 1 | 2011 | 1005 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2003 | 2761 | 0.020 |
Why?
|
| Curriculum | 1 | 2018 | 3780 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 29915 | 0.010 |
Why?
|
| Diet | 1 | 2022 | 8085 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1997 | 6408 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1995 | 938 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15832 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20680 | 0.010 |
Why?
|
| Receptors, Opioid, mu | 1 | 2004 | 165 | 0.010 |
Why?
|
| Formaldehyde | 1 | 2004 | 354 | 0.010 |
Why?
|
| Exercise | 1 | 1999 | 5937 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15645 | 0.010 |
Why?
|
| Rats | 3 | 2004 | 23707 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10803 | 0.010 |
Why?
|
| Isoindoles | 1 | 2000 | 35 | 0.010 |
Why?
|
| Linear Models | 1 | 2011 | 5873 | 0.010 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2000 | 133 | 0.010 |
Why?
|
| Pain Threshold | 1 | 2004 | 604 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 59849 | 0.010 |
Why?
|
| Methylhistidines | 1 | 1999 | 35 | 0.010 |
Why?
|
| Light | 1 | 1995 | 1364 | 0.010 |
Why?
|
| Patients' Rooms | 1 | 1999 | 63 | 0.010 |
Why?
|
| Catheterization | 1 | 2004 | 1434 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 30215 | 0.010 |
Why?
|
| Naltrexone | 1 | 2000 | 319 | 0.010 |
Why?
|
| Reaction Time | 1 | 2004 | 2086 | 0.010 |
Why?
|
| Utilization Review | 1 | 1999 | 381 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2004 | 1866 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2844 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 3053 | 0.010 |
Why?
|
| Drug Design | 1 | 2000 | 1040 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1999 | 1603 | 0.010 |
Why?
|
| Neoplasms | 1 | 2024 | 22349 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 3435 | 0.010 |
Why?
|
| Animals | 4 | 2004 | 168730 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74853 | 0.010 |
Why?
|
| Abdomen | 1 | 1999 | 1133 | 0.010 |
Why?
|
| HIV Infections | 1 | 1999 | 17530 | 0.010 |
Why?
|
| Virus Replication | 1 | 1999 | 2446 | 0.010 |
Why?
|
| Program Evaluation | 1 | 1999 | 2501 | 0.010 |
Why?
|
| Neutrophils | 1 | 1999 | 3770 | 0.000 |
Why?
|
| Emergency Medical Services | 1 | 1997 | 1936 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1997 | 12421 | 0.000 |
Why?
|